PolicyChanges tracks payer policy changes for medical practices and tells you what to do before they take effect.

Create a free accountPolicy Monitoring is free. No card required.
← Back to list
PacificSource Health PlansCommercial · Coverage · Prior Authorization · OR, ID, MT, WA · Cardiology, Endocrinology, Gastroenterology +9 moreHigh impact

October 2026 Drug List Change Notification (Commercial)

Act
by Oct 22, 2026
Effective date
Oct 22, 2026
Identified
Aug 21, 2026

Summary

Effective October 22, 2026, PacificSource is implementing major formulary changes affecting 40+ medications across commercial and state-based plans (OR, ID, MT, WA). Changes include new drug additions at various tiers with prior authorization and quantity limits, removal of brand-name drugs with generic alternatives, and updates to prior authorization criteria for multiple drug classes. Billing teams must update systems to reflect new tier placements, prior authorization requirements, and quantity limit enforcement.

Get alerts when payers change rules like this one

We check PacificSource Health Plans and other payers every day and email you when a change matches your specialty and state.

Get PacificSource Health Plans alertsPolicy Monitoring is free. No card required.

What to do

by Oct 22, 2026 · 7 steps
01Billing team must update pharmacy benefit system to reflect 40+ new formulary additions with correct tier levels, prior authorization flags, quantity limits, and specialty pharmacy (SP) designations.
02Update prior authorization workflow for all new drugs requiring PA, including medical necessity determinations for medications like Atuncy, Awiqli, Bysanti, Quiofic, and Ryaltris.
03Implement quantity limit enforcement in billing system for affected drugs (Tremfya, Uptravi, and all tier 3+ additions).
04For state-based plans (OR, ID, MT, WA), apply different tier levels (tier 4 vs tier 3 for most drugs).
05Remove from formulary and direct patients to generic alternatives: Bosulif, Gamastan, Janumet, Janumet XR, Januvia, Jynarque, Nucynta, Nuedexta, Opsumit, Pomalyst, Sandostatin, Tasigna, Torisel, Xeljanz (all forms).
06Update encounter forms and prior auth templates to capture medical necessity documentation for applicable medications.
07Coordinate with providers to communicate tier changes and generic substitutions.
If missed: Failure to implement changes will result in claim denials and patient out-of-pocket cost disputes.

Original notice

October 2026 Drug List Change Notification (Commercial)
pacificsource.com · Always check the source before changing claims.
View original ↗

Related policy hubs

Summaries are AI-assisted. Always confirm against the original payer notice.

What is PolicyChanges

One workspace for payer rules, prior auth, coding and compliance

Medical practices use PolicyChanges to catch payer changes before they cause denials. Every change is summarized in plain English, with the codes involved, the date it takes effect and what to do.

Start freePolicy Monitoring is free. No card required.
Get alerts for changes like thisPolicy Monitoring is free. No card required.Create a free account